Development and In Vivo Evaluation of Small-Molecule Ligands for Positron Emission Tomography of Immune Checkpoint Modulation Targeting Programmed Cell Death 1 Ligand 1
Karsten Bamminger, Verena Pichler, Chrysoula Vraka, Tanja Limberger et autres
High Resolution Image Download MS PowerPoint Slide A substantial portion of patients do not benefit from programmed cell death protein 1/programmed cell death 1 ligand 1 (PD-1/PD-L1) checkpoint inhibition therapies, necessitating a deeper understanding of predictive biomarkers. Immunohistochemistry (IHC) has played a …
at, de (code pays fourni par la source)